EUVIMEDEUVIMED entdecken
Crossref

Transmural Healing Assessed by Combination of Fecal Calprotectin and Intestinal Ultrasonography Is Associated With Reduced Risk of Bowel Damage Progression in Patients With Crohn’s Disease

Julie Huet, Kelly Mathieu, Marie Dodel, Dilek Coban, Maëva Bazoge, Bruno Pereira iD, Anthony Buisson iD

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izaf068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Julie Huet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Université Clermont Auvergne, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Crohn Disease, Feces, Wound Healing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fecal calprotectin (Fcal) and intestinal ultrasonography (IUS) could be used as noninvasive tools to monitor mucosal and transmural healing, respectively, in Crohn’s disease (CD). We assessed the agreement between Fcal and IUS to detect active CD and investigated their complementary to predict long-term CD outcomes.

Methods

In this prospective study, we consecutively included CD patients with concomitant IUS and Fcal testing within 7 days. Patients were divided into 4 groups: Transmural healing (TH; both normal), IUS healing (Fcal > 100 µg/g but normal IUS), biochemical remission reflecting mucosal healing (MH; Fcal < 100 µg/g but abnormal IUS), and no healing (abnormal Fcal and IUS). The primary endpoint was active CD. The secondary endpoints were time to bowel damage progression, time to relapse-related drug discontinuation, and patients’ acceptability (10-points acceptability numerical scale).

Results

Among the included 112 patients, 44.6% (50/112), 12.5% (14/112),16.1% (18/112), and 26.8% (30/122) achieved TH, IUS healing, biochemical remission, and no healing, respectively. The agreement between IUS and Fcal to detect an active CD was poor (71.4%, κ-coefficient = 0.41 ± 0.09). Transmural healing was associated with a reduced risk of bowel damage progression compared to no healing (P < .0001) contrary to IUS healing (P = .15) or biochemical remission (P = .84). Transmural healing was associated with a lower risk of relapse-related drug discontinuation than MH (hazard ratio [HR] = 0.09 [0.02-0.45], P = .003), IUS healing (HR = 0.10 [0.02-0.60], P = .001), or no healing (HR = 0.09 [0.018-0.04], P = .002). IUS was better accepted than Fcal testing (9.6 ± 0.8 vs 7.9 ± 2.3; P < .0001, 10-points range-acceptability numerical scale).

Conclusions

Transmural healing, evaluated by the combination of noninvasive and well-accepted tools such as Fcal and IUS, is associated with improved long-term outcomes and could be used to monitor patients with CD in daily practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocyte L1 Antigen ComplexCrohn DiseaseFecesWound HealingIntestinal MucosaIntestinesHumansFemaleMaleProspective StudiesAdultUltrasonographyDisease ProgressionMiddle AgedYoung AdultBiomarkersPrognosisFollow-Up Studies

Stichwörter der Autor:innen

Crohn’s diseasebowel damagefecal calprotectinintestinal ultrasoundmonitoringtransmural healing

Substanzen

Leukocyte L1 Antigen ComplexBiomarkers

Autor:innen und Institutionen

  • Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Université Clermont Auvergne, Clermont-Ferrand, France.
  • CHU Clermont-Ferrand, DRCI, Unité de Biostatistiques, Université Clermont Auvergne, Clermont-Ferrand, France.
  • Inserm U1071, M2iSH, USC-INRA 2018, Université Clermont Auvergne, Clermont-Ferrand, France.

ORCID-Profile: Bruno Pereira, Anthony Buisson

Zitieren

APA

Huet, J., Mathieu, K., Dodel, M., Coban, D., Bazoge, M., Pereira, B., & Buisson, A. (2025). Transmural Healing Assessed by Combination of Fecal Calprotectin and Intestinal Ultrasonography Is Associated With Reduced Risk of Bowel Damage Progression in Patients With Crohn’s Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf068

Vancouver

Huet J, Mathieu K, Dodel M, Coban D, Bazoge M, Pereira B, et al. Transmural Healing Assessed by Combination of Fecal Calprotectin and Intestinal Ultrasonography Is Associated With Reduced Risk of Bowel Damage Progression in Patients With Crohn’s Disease. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf068

BibTeX
@article{Huet2025,
  author = {Huet, Julie and Mathieu, Kelly and Dodel, Marie and Coban, Dilek and Bazoge, Maëva and Pereira, Bruno and Buisson, Anthony},
  title = {Transmural Healing Assessed by Combination of Fecal Calprotectin and Intestinal Ultrasonography Is Associated With Reduced Risk of Bowel Damage Progression in Patients With Crohn’s Disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izaf068}
}
Kostenlos starten →